[Checklist] Serialization Readiness Checklist 2026 (L1–L5)
Table of Contents
Serialization Readiness Checklist 2026 (L1–L5)
Are you actually ready for serialization changes in 2026?
Most pharma companies say they are. Very few have actually checked.
Regulatory updates, new markets, system upgrades, partner changes – none of these test a single tool. They test the entire L1–L5 serialization setup.
This checklist helps you assess whether your current architecture can absorb change without disrupting operations.
Why This Checklist Exists
This is not educational content. It’s a diagnostic one.
Most serialization issues don’t appear during implementation, but later, when operations are under pressure.
Teams often discover too late that:
- compliance works on paper
- reporting is fragmented
- manual work increases with every change
This checklist is designed to surface structural risks early, before they turn into delays, rework, or operational disruption.
WHAT THE CHECKLIST COVERS (L1–L5)
- Is accountability clear across IT, QA, and Operations?
- Are exceptions and rework controlled — or handled manually?
- Is there a clear source of truth for data and reporting?
- Are systems integrated or running in parallel?
- Can discrepancies be traced and resolved quickly?
- Is business continuity considered in the design?
- Can your setup absorb new markets and regulations without rework?
Who This Checklist is for
- are already live with serialization
- operate across multiple sites or markets
- expect regulatory, operational, or system changes in 2026
Download the Serialization Readiness Checklist 2026
- Short, practical PDF
- Designed for IT, Operations, and Compliance leaders
- No gated sales flow
- No follow-up pressure
Want to review your results with an expert?
If the checklist surfaced critical gaps, we support pharma teams in reviewing serialization readiness across the full L1–L5 ecosystem before changes make those gaps costly.